Shares of the pharmaceutical giant fell Tuesday as investors respond to lower projected sales for Pfizer’s core products combatting Covid-19.
Shares of the pharmaceutical giant fell Tuesday as investors respond to lower projected sales for Pfizer’s core products combatting Covid-19.